PubRank

Claudio Lunardi

Author PubWeight™ 49.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009 4.48
2 Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 2013 3.81
3 Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2009 2.75
4 N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH. Rheumatol Int 2007 2.03
5 Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011 1.80
6 Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 2003 1.64
7 Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int 2010 1.59
8 In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006 1.34
9 A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet 2011 1.24
10 Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet 2012 1.17
11 Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 2005 1.03
12 A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet 2013 0.94
13 Dermatomyositis complicated with Kaposi sarcoma: a case report. Clin Rheumatol 2006 0.92
14 Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment. Int Immunol 2009 0.91
15 The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS One 2013 0.91
16 A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis. Arthritis Res Ther 2012 0.90
17 Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis 2012 0.89
18 Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report. J Med Invest 2007 0.89
19 Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta 2006 0.88
20 Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Rheumatology (Oxford) 2011 0.88
21 Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res Ther 2014 0.87
22 Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence? Dig Liver Dis 2011 0.86
23 Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis. Ann Rheum Dis 2011 0.85
24 Sensori-neural deafness and hypothyroidism: autoimmunity causing 'pseudo-Pendred syndrome'. Horm Res 2006 0.84
25 Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis 2012 0.83
26 Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. Arthritis Res Ther 2012 0.83
27 Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome. J Autoimmun 2005 0.82
28 Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. Autoimmunity 2013 0.82
29 In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells. PLoS One 2013 0.81
30 Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther 2010 0.81
31 DNase I behaves as a transcription factor which modulates Fas expression in human cells. Eur J Immunol 2004 0.81
32 Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. J Rheumatol 2007 0.80
33 A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84. Immunol Res 2013 0.80
34 A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility. Arthritis Res Ther 2014 0.80
35 The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J Rheumatol 2003 0.80
36 [HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations]. Recenti Prog Med 2005 0.79
37 Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus. Arthritis Rheumatol 2014 0.78
38 Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature. Autoimmun Rev 2011 0.78
39 Occupational allergic contact dermatitis from champignon and Polish mushroom. Contact Dermatitis 2004 0.77
40 Leprosy initially misdiagnosed as sarcoidosis, adult-onset still disease, or autoinflammatory disease. J Clin Rheumatol 2011 0.77
41 The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions. J Rheumatol 2002 0.77
42 The role of peptide libraries in the identification of novel autoantigen targets in autoimmune diseases. Discov Med 2010 0.76
43 Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease. Int Immunol 2012 0.76
44 Reactive arthritis following BCG immunotherapy for bladder carcinoma. Clin Rheumatol 2005 0.75
45 The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis. Isr Med Assoc J 2002 0.75
46 Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis. Int Immunol 2010 0.75
47 KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor. Arthritis Res Ther 2012 0.75
48 Modulation of adaptive immune response following intravenous immunoglobulin therapy in common variable immunodeficiency. Isr Med Assoc J 2014 0.75
49 An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis. J Rheumatol 2017 0.75
50 Systemic sclerosis and superficial siderosis of the central nervous system: casuality or causality? Rheumatol Int 2008 0.75